Evidence map›Paper›PMID 40428648›Full record

ReviewMicromachines2025

Advancements in Wearable and Implantable BioMEMS Devices: Transforming Healthcare Through Technology.

Vishnuram Abhinav, Prithvi Basu, Shikha Supriya Verma, Jyoti Verma, Atanu Das, Savita Kumari, Prateek Ranjan Yadav, Vibhor Kumar

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vishnuram AbhinavDepartment of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai 400076, Maharashtra, India.ORCID 0000-0001-5115-9423
Prithvi BasuDepartment of Electrical Engineering, Texas A&M University, College Station, TX 77843, USA.
Shikha Supriya VermaIntegrated Disease Surveillance Program, National Health Mission, Guwahati 781005, Assam, India.
Jyoti VermaDepartment of Electrical Engineering, Texas A&M University, College Station, TX 77843, USA.
Atanu DasDepartment of Electronics and Communication Engineering, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.ORCID 0000-0002-1733-626X
Savita KumariDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai 400076, Maharashtra, India.ORCID 0009-0008-7040-8067
Prateek Ranjan YadavSchool of Mechanical and Materials Engineering, University College Dublin, D04 V1W8 Dublin, Ireland.
Vibhor KumarDepartment of Electrical Engineering, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0003-3186-6635

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wearable and implantable BioMEMSs (biomedical microelectromechanical systems) have transformed modern healthcare by enabling continuous, personalized, and minimally invasive monitoring, diagnostics, and therapy. Wearable BioMEMSs have advanced rapidly, encompassing a diverse range of biosensors, bioelectronic systems, drug delivery platforms, and motion tracking technologies. These devices enable non-invasive, real-time monitoring of biochemical, electrophysiological, and biomechanical signals, offering personalized and proactive healthcare solutions. In parallel, implantable BioMEMS have significantly enhanced long-term diagnostics, targeted drug delivery, and neurostimulation. From continuous glucose and intraocular pressure monitoring to programmable drug delivery and bioelectric implants for neuromodulation, these devices are improving precision treatment by continuous monitoring and localized therapy. This review explores the materials and technologies driving advancements in wearable and implantable BioMEMSs, focusing on their impact on chronic disease management, cardiology, respiratory care, and glaucoma treatment. We also highlight their integration with artificial intelligence (AI) and the Internet of Things (IoT), paving the way for smarter, data-driven healthcare solutions. Despite their potential, BioMEMSs face challenges such as regulatory complexities, global standardization, and societal determinants. Looking ahead, we explore emerging directions like multifunctional systems, biodegradable power sources, and next-generation point-of-care diagnostics. Collectively, these advancements position BioMEMS as pivotal enablers of future patient-centric healthcare systems.

Indexed as

biocompatible materialsbioMEMScardiac monitoringchronic disease managementdrug deliveryhealthcare monitoringimplantable devicespoint of caresocietal determinantswearable medical devices

Identifiers

PMID40428648
PMCPMC12113605

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.